Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Hims & Hers Health, Inc.HIMS · Entity 1878 | Chief Financial Officer | October 01, 2026 | October 03, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Hims & Hers Health, Inc.
Report date October 01, 2026 · Filed October 03, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class A Common StockSEC Table I · non-derivative | Direct | 234,527 |
Reported balance
After 2026-10-01 transaction · row 1
1 source rowRow 1 · 2026-10-01 · Sale · Disposed 2,000 · Balance 234,527 F1: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on May 20, 2026 by the Reporting Person. |
Filing footnotes · ownership attribution and instrument terms
F1: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on May 20, 2026 by the Reporting Person.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| October 01, 2026 Filed Oct 3, 2026 00:32 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | SaleClass A Common Stock | 2,000 | $29.70 | $59,400.00 |
DisclosureSEC source: 0001907056-26-000028 · wk-form4_1790973122.xml · nonDerivative · entry 1 Okupe Oluyemi · CIK 0001907056 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 234,527 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on May 20, 2026 by the Reporting Person. Read SEC document |
| September 22, 2026 Filed Sep 23, 2026 20:17 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | Exercise / conversionStock Option (right to buy) · Derivative | 14,000 | $0.00 Strike: $5.01 | $0.00 |
DisclosureSEC source: 0001907056-26-000026 · wk-form4_1790194630.xml · derivative · entry 4 Okupe Oluyemi · CIK 0001907056 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 66,872 Underlying: Class A Common Stock · 14,000 shares Expires 2032-02-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on May 20, 2026 by the Reporting Person. F2 · derivative.exercise_date: This stock option award is fully vested. Read SEC document |
| September 22, 2026 Filed Sep 23, 2026 20:17 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | SaleClass A Common Stock | 29,277 | $29.95 | $876,846.15 |
DisclosureSEC source: 0001907056-26-000026 · wk-form4_1790194630.xml · nonDerivative · entry 2 Okupe Oluyemi · CIK 0001907056 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 236,527 F1 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on May 20, 2026 by the Reporting Person. Read SEC document |
| September 22, 2026 Filed Sep 23, 2026 20:17 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | Exercise / conversionClass A Common Stock | 14,000 | $5.01 | $70,140.00 |
DisclosureSEC source: 0001907056-26-000026 · wk-form4_1790194630.xml · nonDerivative · entry 1 Okupe Oluyemi · CIK 0001907056 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 265,804 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on May 20, 2026 by the Reporting Person. Read SEC document |
| September 17, 2026 Filed Sep 18, 2026 20:17 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | SaleClass A Common Stock | 12,313 | $28.82 | $354,860.66 |
DisclosureSEC source: 0001907056-26-000024 · wk-form4_1789762639.xml · nonDerivative · entry 1 Okupe Oluyemi · CIK 0001907056 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 251,804 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on May 20, 2026 by the Reporting Person. Read SEC document |
| August 19, 2026 Filed Aug 20, 2026 20:30 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | Exercise / conversionStock Option (right to buy) · Derivative | 4,938 | $0.00 Strike: $5.01 | $0.00 |
DisclosureSEC source: 0001907056-26-000022 · wk-form4_1787257834.xml · derivative · entry 4 Okupe Oluyemi · CIK 0001907056 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 80,872 Underlying: Class A Common Stock · 4,938 shares Expires 2032-02-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on May 21, 2025 by the Reporting Person. F3 · derivative.exercise_date: 25% of the options will vest on the twelve (12) month anniversary of the Vesting Commencement Date of January 24, 2022. The balance of the shares shall vest in a series of thirty-six (36) successive equal monthly installments measured from the twelve (12) month anniversary of the Vesting Commencement Date, subject to optionholder's continuous Service (as defined in the Plan) as of each such vesting date. Read SEC document |
| August 19, 2026 Filed Aug 20, 2026 20:30 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | SaleClass A Common Stock | 4,938 | $29.99 | $148,111.36 |
DisclosureSEC source: 0001907056-26-000022 · wk-form4_1787257834.xml · nonDerivative · entry 2 Okupe Oluyemi · CIK 0001907056 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 264,117 F1 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on May 21, 2025 by the Reporting Person. F2 · price: Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $29.95 - $30.0450. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. Read SEC document |
| August 19, 2026 Filed Aug 20, 2026 20:30 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | Exercise / conversionClass A Common Stock | 4,938 | $5.01 | $24,739.38 |
DisclosureSEC source: 0001907056-26-000022 · wk-form4_1787257834.xml · nonDerivative · entry 1 Okupe Oluyemi · CIK 0001907056 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 269,055 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on May 21, 2025 by the Reporting Person. Read SEC document |
| August 17, 2026 Filed Aug 18, 2026 21:04 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | Exercise / conversionStock Option (right to buy) · Derivative | 9,388 | $0.00 Strike: $5.01 | $0.00 |
DisclosureSEC source: 0001773751-26-000210 · wk-form4_1787087043.xml · derivative · entry 10 Okupe Oluyemi · CIK 0001907056 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 85,810 Underlying: Class A Common Stock · 9,388 shares Expires 2032-02-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on May 21, 2025 by the Reporting Person. F10 · derivative.exercise_date: This stock option award is fully vested. Read SEC document |
| August 17, 2026 Filed Aug 18, 2026 21:04 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | SaleClass A Common Stock | 9,388 | $27.89 | $261,802.22 |
DisclosureSEC source: 0001773751-26-000210 · wk-form4_1787087043.xml · nonDerivative · entry 5 Okupe Oluyemi · CIK 0001907056 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 264,117 F1 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on May 21, 2025 by the Reporting Person. F5 · price: Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $27.59 - $28.105. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. Read SEC document |
| August 17, 2026 Filed Aug 18, 2026 21:04 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | Exercise / conversionClass A Common Stock | 9,388 | $5.01 | $47,033.88 |
DisclosureSEC source: 0001773751-26-000210 · wk-form4_1787087043.xml · nonDerivative · entry 4 Okupe Oluyemi · CIK 0001907056 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 273,505 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on May 21, 2025 by the Reporting Person. Read SEC document |
| August 14, 2026 Filed Aug 18, 2026 21:04 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | Exercise / conversionRestricted Stock Unit · Derivative | 18,811 | $0.00 | $0.00 |
DisclosureSEC source: 0001773751-26-000210 · wk-form4_1787087043.xml · derivative · entry 9 Okupe Oluyemi · CIK 0001907056 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 263,356 Underlying: Class A Common Stock · 18,811 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: The Restricted Stock Units ("RSUs") represent a contingent right to receive one share of Class A Common Stock for each RSU. F9 · derivative.exercise_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with the RSUs vesting in substantially equal quarterly installments on the Company's quarterly vesting dates, with the first such vesting date on June 15, 2026. F9 · derivative.expiration_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with the RSUs vesting in substantially equal quarterly installments on the Company's quarterly vesting dates, with the first such vesting date on June 15, 2026. Read SEC document |
| August 14, 2026 Filed Aug 18, 2026 21:04 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | Exercise / conversionRestricted Stock Unit · Derivative | 11,482 | $0.00 | $0.00 |
DisclosureSEC source: 0001773751-26-000210 · wk-form4_1787087043.xml · derivative · entry 8 Okupe Oluyemi · CIK 0001907056 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 114,825 Underlying: Class A Common Stock · 11,482 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: The Restricted Stock Units ("RSUs") represent a contingent right to receive one share of Class A Common Stock for each RSU. F8 · derivative.exercise_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with the RSUs vesting in substantially equal quarterly installments on the Company's quarterly vesting dates, with the first such vesting date on June 15, 2025. F8 · derivative.expiration_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with the RSUs vesting in substantially equal quarterly installments on the Company's quarterly vesting dates, with the first such vesting date on June 15, 2025. Read SEC document |
| August 14, 2026 Filed Aug 18, 2026 21:04 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | Exercise / conversionRestricted Stock Unit · Derivative | 22,988 | $0.00 | $0.00 |
DisclosureSEC source: 0001773751-26-000210 · wk-form4_1787087043.xml · derivative · entry 7 Okupe Oluyemi · CIK 0001907056 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 137,929 Underlying: Class A Common Stock · 22,988 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: The Restricted Stock Units ("RSUs") represent a contingent right to receive one share of Class A Common Stock for each RSU. F7 · derivative.exercise_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with the RSUs vesting in substantially equal quarterly installments on the Company's quarterly vesting dates, with the first such vesting date on June 15, 2024. F7 · derivative.expiration_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with the RSUs vesting in substantially equal quarterly installments on the Company's quarterly vesting dates, with the first such vesting date on June 15, 2024. Read SEC document |
| August 14, 2026 Filed Aug 18, 2026 21:04 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | Exercise / conversionRestricted Stock Unit · Derivative | 18,335 | $0.00 | $0.00 |
DisclosureSEC source: 0001773751-26-000210 · wk-form4_1787087043.xml · derivative · entry 6 Okupe Oluyemi · CIK 0001907056 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 36,669 Underlying: Class A Common Stock · 18,335 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: The Restricted Stock Units ("RSUs") represent a contingent right to receive one share of Class A Common Stock for each RSU. F6 · derivative.exercise_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with the RSUs vesting in substantially equal quarterly installments on the Company's quarterly vesting dates, with the first such vesting date on June 15, 2023. F6 · derivative.expiration_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with the RSUs vesting in substantially equal quarterly installments on the Company's quarterly vesting dates, with the first such vesting date on June 15, 2023. Read SEC document |
| August 14, 2026 Filed Aug 18, 2026 21:04 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | Tax withholdingClass A Common Stock | 36,437 | $28.15 | $1,025,701.55 |
DisclosureSEC source: 0001773751-26-000210 · wk-form4_1787087043.xml · nonDerivative · entry 3 Okupe Oluyemi · CIK 0001907056 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 264,117 F4 · shares: The shares of Class A Common Stock were withheld by the issuer to cover tax withholding obligations in connection with the reported vesting and settlement of RSUs. Read SEC document |
| August 14, 2026 Filed Aug 18, 2026 21:04 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | Exercise / conversionClass A Common Stock | 71,616 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001773751-26-000210 · wk-form4_1787087043.xml · nonDerivative · entry 2 Okupe Oluyemi · CIK 0001907056 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 300,554 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · price: The Restricted Stock Units ("RSUs") represent a contingent right to receive one share of Class A Common Stock for each RSU. Read SEC document |
| July 17, 2026 Filed Jul 20, 2026 20:30 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | Exercise / conversionStock Option (right to buy) · Derivative | 7,163 | $0.00 Strike: $5.01 | $0.00 |
DisclosureSEC source: 0001907056-26-000020 · wk-form4_1784579422.xml · derivative · entry 4 Okupe Oluyemi · CIK 0001907056 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 95,198 Underlying: Class A Common Stock · 7,163 shares Expires 2032-02-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on May 21, 2025 by the Reporting Person. F3 · derivative.exercise_date: 25% of the options will vest on the twelve (12) month anniversary of the Vesting Commencement Date of January 24, 2022. The balance of the shares shall vest in a series of thirty-six (36) successive equal monthly installments measured from the twelve (12) month anniversary of the Vesting Commencement Date, subject to optionholder's continuous Service (as defined in the Plan) as of each such vesting date. Read SEC document |
| July 17, 2026 Filed Jul 20, 2026 20:30 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | SaleClass A Common Stock | 7,163 | $31.99 | $229,168.01 |
DisclosureSEC source: 0001907056-26-000020 · wk-form4_1784579422.xml · nonDerivative · entry 2 Okupe Oluyemi · CIK 0001907056 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 284,321 F1 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on May 21, 2025 by the Reporting Person. F2 · price: Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $31.93 - $32.06. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. Read SEC document |
| July 17, 2026 Filed Jul 20, 2026 20:30 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | Exercise / conversionClass A Common Stock | 7,163 | $5.01 | $35,886.63 |
DisclosureSEC source: 0001907056-26-000020 · wk-form4_1784579422.xml · nonDerivative · entry 1 Okupe Oluyemi · CIK 0001907056 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 291,484 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on May 21, 2025 by the Reporting Person. Read SEC document |
| July 06, 2026 Filed Jul 7, 2026 20:20 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | Exercise / conversionStock Option (right to buy) · Derivative | 7,163 | $0.00 Strike: $5.01 | $0.00 |
DisclosureSEC source: 0001907056-26-000018 · wk-form4_1783455644.xml · derivative · entry 4 Okupe Oluyemi · CIK 0001907056 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 102,361 Underlying: Class A Common Stock · 7,163 shares Expires 2032-02-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on May 21, 2025 by the Reporting Person. F3 · derivative.exercise_date: 25% of the options will vest on the twelve (12) month anniversary of the Vesting Commencement Date of January 24, 2022. The balance of the shares shall vest in a series of thirty-six (36) successive equal monthly installments measured from the twelve (12) month anniversary of the Vesting Commencement Date, subject to optionholder's continuous Service (as defined in the Plan) as of each such vesting date. Read SEC document |
| July 06, 2026 Filed Jul 7, 2026 20:20 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | SaleClass A Common Stock | 7,163 | $36.49 | $261,351.37 |
DisclosureSEC source: 0001907056-26-000018 · wk-form4_1783455644.xml · nonDerivative · entry 2 Okupe Oluyemi · CIK 0001907056 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 284,321 F1 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on May 21, 2025 by the Reporting Person. F2 · price: Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $36.35 - $36.70. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. Read SEC document |
| July 06, 2026 Filed Jul 7, 2026 20:20 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | Exercise / conversionClass A Common Stock | 7,163 | $5.01 | $35,886.63 |
DisclosureSEC source: 0001907056-26-000018 · wk-form4_1783455644.xml · nonDerivative · entry 1 Okupe Oluyemi · CIK 0001907056 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 291,484 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on May 21, 2025 by the Reporting Person. Read SEC document |
| June 22, 2026 Filed Jun 23, 2026 22:39 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | Exercise / conversionStock Option (right to buy) · Derivative | 6,376 | $0.00 Strike: $5.01 | $0.00 |
DisclosureSEC source: 0001773751-26-000135 · wk-form4_1782254365.xml · derivative · entry 4 Okupe Oluyemi · CIK 0001907056 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 109,524 Underlying: Class A Common Stock · 6,376 shares Expires 2032-02-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on May 21, 2025 by the Reporting Person. F3 · derivative.exercise_date: 25% of the options will vest on the twelve (12) month anniversary of the Vesting Commencement Date of January 24, 2022. The balance of the shares shall vest in a series of thirty-six (36) successive equal monthly installments measured from the twelve (12) month anniversary of the Vesting Commencement Date, subject to optionholder's continuous Service (as defined in the Plan) as of each such vesting date. Read SEC document |
| June 22, 2026 Filed Jun 23, 2026 22:39 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | SaleClass A Common Stock | 18,197 | $34.03 | $619,216.61 |
DisclosureSEC source: 0001773751-26-000135 · wk-form4_1782254365.xml · nonDerivative · entry 2 Okupe Oluyemi · CIK 0001907056 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 284,321 F1 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on May 21, 2025 by the Reporting Person. F2 · price: Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $33.65 - $34.57. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. Read SEC document |
| June 22, 2026 Filed Jun 23, 2026 22:39 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | Exercise / conversionClass A Common Stock | 6,376 | $5.01 | $31,943.76 |
DisclosureSEC source: 0001773751-26-000135 · wk-form4_1782254365.xml · nonDerivative · entry 1 Okupe Oluyemi · CIK 0001907056 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 302,518 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on May 21, 2025 by the Reporting Person. Read SEC document |
| June 18, 2026 Filed Aug 18, 2026 21:04 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | SaleClass A Common Stock | 55,383 | $35.09 | $1,943,389.47 |
DisclosureSEC source: 0001773751-26-000210 · wk-form4_1787087043.xml · nonDerivative · entry 1 Okupe Oluyemi · CIK 0001907056 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 228,938 F1 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on May 21, 2025 by the Reporting Person. F2 · price: Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $34.95 - $35.36. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. Read SEC document |
| June 15, 2026 Filed Jun 17, 2026 22:51 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | Exercise / conversionRestricted Stock Unit · Derivative | 18,811 | $0.00 | $0.00 |
DisclosureSEC source: 0001773751-26-000131 · wk-form4_1781736659.xml · derivative · entry 7 Okupe Oluyemi · CIK 0001907056 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 282,167 Underlying: Class A Common Stock · 18,811 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The Restricted Stock Units ("RSUs") represent a contingent right to receive one share of Class A Common Stock for each RSU. F7 · derivative.exercise_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with the RSUs vesting in substantially equal quarterly installments on the Company's quarterly vesting dates, with the first such vesting date on June 15, 2026. F7 · derivative.expiration_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with the RSUs vesting in substantially equal quarterly installments on the Company's quarterly vesting dates, with the first such vesting date on June 15, 2026. Read SEC document |
| June 15, 2026 Filed Jun 17, 2026 22:51 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | Exercise / conversionRestricted Stock Unit · Derivative | 11,483 | $0.00 | $0.00 |
DisclosureSEC source: 0001773751-26-000131 · wk-form4_1781736659.xml · derivative · entry 6 Okupe Oluyemi · CIK 0001907056 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 126,307 Underlying: Class A Common Stock · 11,483 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The Restricted Stock Units ("RSUs") represent a contingent right to receive one share of Class A Common Stock for each RSU. F6 · derivative.exercise_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with the RSUs vesting in substantially equal quarterly installments on the Company's quarterly vesting dates, with the first such vesting date on June 15, 2025. F6 · derivative.expiration_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with the RSUs vesting in substantially equal quarterly installments on the Company's quarterly vesting dates, with the first such vesting date on June 15, 2025. Read SEC document |
| June 15, 2026 Filed Jun 17, 2026 22:51 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | Exercise / conversionRestricted Stock Unit · Derivative | 22,988 | $0.00 | $0.00 |
DisclosureSEC source: 0001773751-26-000131 · wk-form4_1781736659.xml · derivative · entry 5 Okupe Oluyemi · CIK 0001907056 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 160,917 Underlying: Class A Common Stock · 22,988 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The Restricted Stock Units ("RSUs") represent a contingent right to receive one share of Class A Common Stock for each RSU. F5 · derivative.exercise_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with the RSUs vesting in substantially equal quarterly installments on the Company's quarterly vesting dates, with the first such vesting date on June 15, 2024. F5 · derivative.expiration_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with the RSUs vesting in substantially equal quarterly installments on the Company's quarterly vesting dates, with the first such vesting date on June 15, 2024. Read SEC document |
| June 15, 2026 Filed Jun 17, 2026 22:51 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | Exercise / conversionRestricted Stock Unit · Derivative | 18,334 | $0.00 | $0.00 |
DisclosureSEC source: 0001773751-26-000131 · wk-form4_1781736659.xml · derivative · entry 4 Okupe Oluyemi · CIK 0001907056 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 55,004 Underlying: Class A Common Stock · 18,334 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The Restricted Stock Units ("RSUs") represent a contingent right to receive one share of Class A Common Stock for each RSU. F4 · derivative.exercise_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with the RSUs vesting in substantially equal quarterly installments on the Company's quarterly vesting dates, with the first such vesting date on June 15, 2023. F4 · derivative.expiration_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with the RSUs vesting in substantially equal quarterly installments on the Company's quarterly vesting dates, with the first such vesting date on June 15, 2023. Read SEC document |
| June 15, 2026 Filed Jun 17, 2026 22:51 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | Tax withholdingClass A Common Stock | 39,541 | $30.17 | $1,192,951.97 |
DisclosureSEC source: 0001773751-26-000131 · wk-form4_1781736659.xml · nonDerivative · entry 2 Okupe Oluyemi · CIK 0001907056 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 296,142 F3 · shares: The shares of Class A Common Stock were withheld by the issuer to cover tax withholding obligations in connection with the reported vesting and settlement of RSUs. Read SEC document |
| June 15, 2026 Filed Jun 17, 2026 22:51 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | Exercise / conversionClass A Common Stock | 71,616 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001773751-26-000131 · wk-form4_1781736659.xml · nonDerivative · entry 1 Okupe Oluyemi · CIK 0001907056 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 335,683 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: The Restricted Stock Units ("RSUs") represent a contingent right to receive one share of Class A Common Stock for each RSU. F2 · balance_after: Includes 1,113 shares acquired on May 20, 2026, under the Hims & Hers Health, Inc. 2020 Employee Stock Purchase Plan. Read SEC document |
| May 18, 2026 Filed May 19, 2026 23:39 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | Exercise / conversionStock Option (right to buy) · Derivative | 7,950 | $0.00 Strike: $5.01 | $0.00 |
DisclosureSEC source: 0001773751-26-000078 · wk-form4_1779233952.xml · derivative · entry 4 Okupe Oluyemi · CIK 0001907056 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 115,900 Underlying: Class A Common Stock · 7,950 shares Expires 2032-02-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on May 21, 2025 by the Reporting Person. F3 · derivative.exercise_date: The stock options are fully vested and exercisable. Read SEC document |
| May 18, 2026 Filed May 19, 2026 23:39 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | SaleClass A Common Stock | 7,950 | $23.64 | $187,915.74 |
DisclosureSEC source: 0001773751-26-000078 · wk-form4_1779233952.xml · nonDerivative · entry 2 Okupe Oluyemi · CIK 0001907056 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 262,954 F1 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on May 21, 2025 by the Reporting Person. F2 · price: Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $23.55- $23.80. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. Read SEC document |
| May 18, 2026 Filed May 19, 2026 23:39 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | Exercise / conversionClass A Common Stock | 7,950 | $5.01 | $39,829.50 |
DisclosureSEC source: 0001773751-26-000078 · wk-form4_1779233952.xml · nonDerivative · entry 1 Okupe Oluyemi · CIK 0001907056 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 270,904 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on May 21, 2025 by the Reporting Person. Read SEC document |
| April 20, 2026 Filed Apr 22, 2026 21:24 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | Exercise / conversionStock Option (right to buy) · Derivative | 7,000 | $0.00 Strike: $11.53 | $0.00 |
DisclosureSEC source: 0001907056-26-000016 · wk-form4_1776893044.xml · derivative · entry 6 Okupe Oluyemi · CIK 0001907056 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 35,996 Underlying: Class A Common Stock · 7,000 shares Expires 2033-03-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on May 21, 2025 by the Reporting Person. F4 · derivative.exercise_date: The options are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with 1/48th of the options vesting monthly, beginning on April 1, 2023. Read SEC document |
| April 20, 2026 Filed Apr 22, 2026 21:24 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | Exercise / conversionStock Option (right to buy) · Derivative | 5,553 | $0.00 Strike: $5.01 | $0.00 |
DisclosureSEC source: 0001907056-26-000016 · wk-form4_1776893044.xml · derivative · entry 5 Okupe Oluyemi · CIK 0001907056 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 123,850 Underlying: Class A Common Stock · 5,553 shares Expires 2032-02-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on May 21, 2025 by the Reporting Person. F3 · derivative.exercise_date: The stock options are fully vested and exercisable. Read SEC document |
| April 20, 2026 Filed Apr 22, 2026 21:24 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | SaleClass A Common Stock | 19,645 | $29.96 | $588,615.28 |
DisclosureSEC source: 0001907056-26-000016 · wk-form4_1776893044.xml · nonDerivative · entry 3 Okupe Oluyemi · CIK 0001907056 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 262,954 F1 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on May 21, 2025 by the Reporting Person. F2 · price: Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $29.95 - $30.005. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. Read SEC document |
| April 20, 2026 Filed Apr 22, 2026 21:24 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | Exercise / conversionClass A Common Stock | 7,000 | $11.53 | $80,710.00 |
DisclosureSEC source: 0001907056-26-000016 · wk-form4_1776893044.xml · nonDerivative · entry 2 Okupe Oluyemi · CIK 0001907056 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 282,599 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on May 21, 2025 by the Reporting Person. Read SEC document |
| April 20, 2026 Filed Apr 22, 2026 21:24 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | Exercise / conversionClass A Common Stock | 5,553 | $5.01 | $27,820.53 |
DisclosureSEC source: 0001907056-26-000016 · wk-form4_1776893044.xml · nonDerivative · entry 1 Okupe Oluyemi · CIK 0001907056 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 275,599 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on May 21, 2025 by the Reporting Person. Read SEC document |
| April 17, 2026 Filed Apr 20, 2026 20:38 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | Exercise / conversionStock Option (right to buy) · Derivative | 6,184 | $0.00 Strike: $5.01 | $0.00 |
DisclosureSEC source: 0001907056-26-000014 · wk-form4_1776717480.xml · derivative · entry 5 Okupe Oluyemi · CIK 0001907056 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 129,403 Underlying: Class A Common Stock · 6,184 shares Expires 2032-02-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on May 21, 2025 by the Reporting Person. F4 · derivative.exercise_date: 25% of the options will vest on the twelve (12) month anniversary of the Vesting Commencement Date of January 24, 2022. The balance of the shares shall vest in a series of thirty-six (36) successive equal monthly installments measured from the twelve (12) month anniversary of the Vesting Commencement Date, subject to optionholder's continuous Service (as defined in the Plan) as of each such vesting date. Read SEC document |
| April 17, 2026 Filed Apr 20, 2026 20:38 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | SaleClass A Common Stock | 18,005 | $27.83 | $501,158.37 |
DisclosureSEC source: 0001907056-26-000014 · wk-form4_1776717480.xml · nonDerivative · entry 3 Okupe Oluyemi · CIK 0001907056 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 270,046 F1 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on May 21, 2025 by the Reporting Person. F3 · price: Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $27.70-$27.97. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. Read SEC document |
| April 17, 2026 Filed Apr 20, 2026 20:38 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | Exercise / conversionClass A Common Stock | 6,184 | $5.01 | $30,981.84 |
DisclosureSEC source: 0001907056-26-000014 · wk-form4_1776717480.xml · nonDerivative · entry 2 Okupe Oluyemi · CIK 0001907056 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 288,051 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on May 21, 2025 by the Reporting Person. Read SEC document |
| April 16, 2026 Filed Apr 20, 2026 20:38 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | SaleClass A Common Stock | 36,922 | $25.90 | $956,146.88 |
DisclosureSEC source: 0001907056-26-000014 · wk-form4_1776717480.xml · nonDerivative · entry 1 Okupe Oluyemi · CIK 0001907056 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 281,867 F1 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on May 21, 2025 by the Reporting Person. F2 · price: Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $25.74-$26.29. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. Read SEC document |
| April 06, 2026 Filed Apr 7, 2026 21:14 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | Exercise / conversionStock Option (right to buy) · Derivative | 3,975 | $0.00 Strike: $5.01 | $0.00 |
DisclosureSEC source: 0001907056-26-000012 · wk-form4_1775596475.xml · derivative · entry 4 Okupe Oluyemi · CIK 0001907056 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 135,587 Underlying: Class A Common Stock · 3,975 shares Expires 2032-02-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on May 21, 2025 by the Reporting Person. F3 · derivative.exercise_date: 25% of the options will vest on the twelve (12) month anniversary of the Vesting Commencement Date of January 24, 2022. The balance of the shares shall vest in a series of thirty-six (36) successive equal monthly installments measured from the twelve (12) month anniversary of the Vesting Commencement Date, subject to optionholder's continuous Service (as defined in the Plan) as of each such vesting date. Read SEC document |
| April 06, 2026 Filed Apr 7, 2026 21:14 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | SaleClass A Common Stock | 3,975 | $19.98 | $79,408.58 |
DisclosureSEC source: 0001907056-26-000012 · wk-form4_1775596475.xml · nonDerivative · entry 2 Okupe Oluyemi · CIK 0001907056 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 318,789 F1 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on May 21, 2025 by the Reporting Person. F2 · price: Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $19.95-$20.02). The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. Read SEC document |
| April 06, 2026 Filed Apr 7, 2026 21:14 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | Exercise / conversionClass A Common Stock | 3,975 | $5.01 | $19,914.75 |
DisclosureSEC source: 0001907056-26-000012 · wk-form4_1775596475.xml · nonDerivative · entry 1 Okupe Oluyemi · CIK 0001907056 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 322,764 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on May 21, 2025 by the Reporting Person. Read SEC document |
| March 20, 2026 Filed Mar 24, 2026 22:09 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | Exercise / conversionStock Option (right to buy) · Derivative | 4,489 | $0.00 Strike: $5.01 | $0.00 |
DisclosureSEC source: 0001773751-26-000051 · wk-form4_1774390195.xml · derivative · entry 4 Okupe Oluyemi · CIK 0001907056 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 139,562 Underlying: Class A Common Stock · 4,489 shares Expires 2032-02-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on May 21, 2025 by the Reporting Person. F3 · derivative.exercise_date: 25% of the options will vest on the twelve (12) month anniversary of the Vesting Commencement Date of January 24, 2022. The balance of the shares shall vest in a series of thirty-six (36) successive equal monthly installments measured from the twelve (12) month anniversary of the Vesting Commencement Date, subject to optionholder's continuous Service (as defined in the Plan) as of each such vesting date. Read SEC document |
| March 20, 2026 Filed Mar 24, 2026 22:09 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | SaleClass A Common Stock | 9,217 | $23.77 | $219,066.89 |
DisclosureSEC source: 0001773751-26-000051 · wk-form4_1774390195.xml · nonDerivative · entry 2 Okupe Oluyemi · CIK 0001907056 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 318,789 F1 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on May 21, 2025 by the Reporting Person. F2 · price: Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $23.73 - $23.92. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.